
Time for a Clinical Trials Revolution – Complex Innovative Design (CID) Cancer Trials
This 1-hour webinar reviews a published consensus statement from the British Journal of Cancer (BJC), looking at recommendations for effective…
Discover the latest in clinical development, trials and data management, from our in-house experts, available on demand now.
A Discussion on Regulatory and Operational Considerations This 1-hour webinar discusses how the COVID-19 pandemic has impacted clinical studies for rare diseases and how patient-centric trial design with regulatory consideration can be utilised to mitigate and manage potential delays and support patient recruitment in rare and orphan clinical trials. About…
This 1-hour webinar reviews a published consensus statement from the British Journal of Cancer (BJC), looking at recommendations for effective…
In this webinar members of our specialist, early phase Project Management team discuss how they tackled the range of challenges…
Click to view Discussion topics include: Key challenges to improve cost-efficiency in clinical development of orphan drugs Regulatory evolution in…
In this webinar the speakers discuss the use of integrated protocols (umbrella protocols) to maximise programme efficiency. Attendees will learn how…
Available to view on demand. If you are embarking on your clinical development plan, consider a non-invasive in vivo evaluation of drug…
Available to view on demand. This one-hour webinar focuses on strategic considerations for the molecule, including a brief review of the…
Available to view on demand. Modular and adaptive clinical trials are rapidly expanding the ability of researchers to modify clinical…
Available to view on demand. Achieving Orphan Drug Designation is a significant step enabling your product to be licensed faster, in a cost-efficient…
If you missed our live ESMO Update: State of the Art in Early Phase Oncology Trial Design webinar you can…